FDA Approves Carl Zeiss Meditec's Cirrus HD-OCT for Dry AMD and Glaucoma

The FDA approved Carl Zeiss Meditec's Cirrus HD-OCT software version 6.0 for dry age-related macular degeneration and glaucoma, according to a company news release.

The system includes Advanced Retinal Pigment Epithelium Analysis, which enables physicians to monitor changes associated with dry AMD, and Enhanced Depth Imaging, which allows physicians to better visualize deep tissues.

Related Articles on Ophthalmology:
Dr. Paul Lee Appointed Director of the W.K. Kellogg Eye Center at University of Michigan
Florida Eye Institute to Offer New and Expanded Range of Lens Implants for Cataract Patients
Scientists Develop Contact Lenses That Provide a Continuous Supply of Anesthetic for Laser Eye Surgery Patients

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast